Vical Incorporated (VICL)
Interview with: Vijay B. Samant, President and CEO
Business News, Financial News, Stocks, Money & Investment Ideas, CEO Interview
and Information on their biopharmaceutical
products based on its patented DNA delivery technologies. |
Cover Story
CEOCFO
Interview Index
CEOCFO
Current Issue
Cover Story
Archives
Future Features
Analyst Interviews
Corporate
Financials
Archived Interviews
About CEOCFOinterviews.com
Contact
& Ordering |
This is a printer friendly page!
Vical
Incorporated is focused on developing vaccines for infectious disease and cancer using
their patented DNA technology
Biotechnology & Drugs
Healthcare
(VICL - NASD)
Vical Incorporated
Vijay B. Samant
President and
Chief Executive Officer
Interview Conducted By:
Diane Reynolds
Associate Publisher
CEOCFOinterviews.com
August 2004
To order the complete August 12, 04 Issue of
CEOCFOinterviews.com left click below:
Purchase NOW!
There
is a $25.00 charge for each archived issue!
disclaimers
Any reproduction or further distribution of this
article without the express written consent of CEOCFOinterviews.com is prohibited.
|
